Next Article in Journal
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer
Next Article in Special Issue
TP53 and the Ultimate Biological Optimization Steps of Curative Radiation Oncology
Previous Article in Journal
Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
Previous Article in Special Issue
Region-Specific Effects of Fractionated Low-Dose Versus Single-Dose Radiation on Hippocampal Neurogenesis and Neuroinflammation
 
 
Article

Article Versions Notes

Cancers 2023, 15(5), 1570; https://doi.org/10.3390/cancers15051570
Action Date Notes Link
article pdf uploaded. 2 March 2023 16:12 CET Version of Record https://www.mdpi.com/2072-6694/15/5/1570/pdf-vor
article xml uploaded. 3 March 2023 03:26 CET Original file https://www.mdpi.com/2072-6694/15/5/1570/xml
article pdf uploaded. 3 March 2023 03:26 CET Updated version of record https://www.mdpi.com/2072-6694/15/5/1570/pdf
article html file updated 3 March 2023 03:28 CET Original file -
article html file updated 20 March 2023 20:24 CET Update https://www.mdpi.com/2072-6694/15/5/1570/html
Back to TopTop